Key facts
- BVI Medical’s last known valuation is $540.0M (Aug 2016).
- It has raised $2.2B; the latest was PE Growth/Expansion ($1.2B) in Mar 2025.
- Notable investors include AustralianSuper, TPG.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BVI Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for BVI Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BVI Medical
Manufacturer of surgical devices intended for patients affected by cataracts, refractive error, glaucoma, retinal disease and dry eye. The company's products include consumables, equipment, intraocular lenses and surgical fluids, thereby delivering innovative and reliable products for a variety of ophthalmic and specialty microsurgical procedures.
- Sector
- Healthcare
- HQ
- Waltham, MA, United States
- Founded
- 1932
- Employees
- 1,016
- Website
- bvimedical.com/
- Ownership
- Privately Held (backing)
BVI Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BVI Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BVI Medical in its N-PORT filings yet. We sweep new filings monthly.